上市技术顾问_临床数据验证_临床试验流程稽查-沙利文官网

Frost & Sullivan provides assurance for the pre-market and clinical trial data of issuers, verifying the preclinical and clinical data disclosed in the issuer's prospectus; and promptly responding to inquiries from regulatory authorities and listing intermediaries regarding data verification.

MAIN SOLUTIONS	As an expert disclosed in the prospectus, we fulfill the regulations applicable to experts under Hong Kong stock, US stock, and domestic STAR Market listing rules Assist the sponsor in answering questions related to clinical trials raised by major exchanges Complete audits of clinical trial processes, preclinical, and clinical data verification Issue on-site base audit reports and discuss the content with the sponsor and lawyers
MAIN ACHIEVEMENTS	We have served many companies listed on Hong Kong stock, US stock, and domestic STAR Market, covering Phase I first-in-human studies, Phase II PoC studies, and Phase III multi-center registration studies. Disease areas include ophthalmic diseases, autoimmune diseases, solid tumors, hematological malignancies, infectious diseases, metabolic diseases, interventional devices, and more

TECHNICAL ADVISORY

Contact Us